1000-7431
2012 Issue 2
..............page:150-151
Mediastinal nonseminoma accompanied by hemophagocytic syndrome:one case report
WANG Mei-xing1;FAN Hong-bin1;TAO Li1;GUO Ye21.Department of Medical Oncology;Minhang Branch of Cancer Hospital of Fudan University;Shanghai 200240;China;2.Department of Medical Oncology;Cancer Hospital of Fudan University;Shanghai 200032;China
WANG Mei-xing1;FAN Hong-bin1;TAO Li1;GUO Ye21.Department of Medical Oncology;Minhang Branch of Cancer Hospital of Fudan University;Shanghai 200240;China;2.Department of Medical Oncology;Cancer Hospital of Fudan University;Shanghai 200032;China
..............page:147-148
Association analysis of the expression level of Nrf2 mRNA in peripheral blood nucleated cells and the severity of chemotherapy-induced myelosuppression
CAO Bao-shan1;QUE Lin-ling2;ZHANG Yu1;CHEN Sen1;YIN Wen-cheng1;WANG Shi-fan2;MA Li-wen1;YU Si-wang2 1.Cancer Treatment Center;Third Hospital;Peking University;Beijing 100191;China;2.Department of Chemical Biology;School of Pharmaceutical Sciences;Peking University;Beijing 100191;China
CAO Bao-shan1;QUE Lin-ling2;ZHANG Yu1;CHEN Sen1;YIN Wen-cheng1;WANG Shi-fan2;MA Li-wen1;YU Si-wang2 1.Cancer Treatment Center;Third Hospital;Peking University;Beijing 100191;China;2.Department of Chemical Biology;School of Pharmaceutical Sciences;Peking University;Beijing 100191;China
..............page:124-129
Association between catechol-O-methyltransferase activity and the development and progression of endometrial cancer
LI Fang1;FU Yan2;LI Jun-yu1;LIU Xue-jing1;LI Li11.Department of Obstetrics and Gynecology;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China;2.New Medicine Research Room;School of Pharmaceutical Sciences;Hebei Medical University;Shijiazhuang 050017;China
LI Fang1;FU Yan2;LI Jun-yu1;LIU Xue-jing1;LI Li11.Department of Obstetrics and Gynecology;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;China;2.New Medicine Research Room;School of Pharmaceutical Sciences;Hebei Medical University;Shijiazhuang 050017;China
..............page:119-123
Molecular biology for myelodysplastic syndrome:an update
LUO Jing;LIU Lin;WANG Li Department of Hematology;First Affiliated Hospital of Chongqing Medical University;Chongqing 400016;China
LUO Jing;LIU Lin;WANG Li Department of Hematology;First Affiliated Hospital of Chongqing Medical University;Chongqing 400016;China
..............page:137-141
Over-expression of transducer of ErbB2,1 inhibits migration and invasion of human lung cancer cell line A549 in vitro
SUN Ke-kang;XU Jia-ying;ZHAO Lin;JIAO YangSuzhou Key Laboratory of Radiation Oncology Biology;Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection;School of Radiation Medicine and Protection;Medical College of Soochow University;Suzhou 215123;China
SUN Ke-kang;XU Jia-ying;ZHAO Lin;JIAO YangSuzhou Key Laboratory of Radiation Oncology Biology;Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection;School of Radiation Medicine and Protection;Medical College of Soochow University;Suzhou 215123;China
..............page:85-91
..............page:152-154
..............page:149
Efficacy and safety of erlotinib as first-line treatment in the elderly patients with advanced non-small cell lung cancer
SU Jin1;XU Xin-hua1;LI Dao-jun1;HUANG Qiao2;LU Ming-qian2;XUE Feng1;YI Fang21.Yichang Central People’s Hospital;First College of Clinical Medical Sciences;China Three Gorges University;Yichang 443003;China;2.Oncology Institute;China Three Gorges University;Yichang 443003;China
SU Jin1;XU Xin-hua1;LI Dao-jun1;HUANG Qiao2;LU Ming-qian2;XUE Feng1;YI Fang21.Yichang Central People’s Hospital;First College of Clinical Medical Sciences;China Three Gorges University;Yichang 443003;China;2.Oncology Institute;China Three Gorges University;Yichang 443003;China
..............page:130-133
Pneumonectomy with intrapericardial ligation of the pulmonary artery and vein:analysis of 130 patients with advanced lung cancer
LUO Guo-jun1;ZHUANG Jiang-neng2;LI Zhuo-dong1;TU Dong1;SHI Yun1;LIU Xin11.Department of Cardio-Thoracic Surgery;Kunming General Hospital of Chengdu Military Command;Kunming 650032;China;2.The 62th Hospital of Chinese People’s Liberation Army;Puer 665000;China
LUO Guo-jun1;ZHUANG Jiang-neng2;LI Zhuo-dong1;TU Dong1;SHI Yun1;LIU Xin11.Department of Cardio-Thoracic Surgery;Kunming General Hospital of Chengdu Military Command;Kunming 650032;China;2.The 62th Hospital of Chinese People’s Liberation Army;Puer 665000;China
..............page:134-136
International evaluation system for adverse events of chemotherapeutic drugs in cancer treatment:CTCAE v4.0
GAO Wen-jun;LIU Yan-yan;YUAN Chang-rongCollege of Nursing;Second Military Medical University;Shanghai 200433;China
GAO Wen-jun;LIU Yan-yan;YUAN Chang-rongCollege of Nursing;Second Military Medical University;Shanghai 200433;China
..............page:142-144
The diagnostic value of serum Golgi protein-73 in hepatocellular carcinoma
LIANG Rong;LUO Xiao-ling;GE Lian-ying;YUAN Wei-ping;YUE Hui-fen;JIA Bao-chang;SHEN Xiao-yun Department of Laboratory Research;Affiliated Cancer Hospital of Guangxi Medical University;Nanning 530021;China
LIANG Rong;LUO Xiao-ling;GE Lian-ying;YUAN Wei-ping;YUE Hui-fen;JIA Bao-chang;SHEN Xiao-yun Department of Laboratory Research;Affiliated Cancer Hospital of Guangxi Medical University;Nanning 530021;China
..............page:115-118
Analysis of incidence and mortality of stomach cancer in China from 2003 to 2007
ZOU Xiao-nong1;SUN Xi-bin2;CHEN Wan-qing1;ZHENG Rong-shou1;ZHANG Si-wei1;DAI Zhen3;LIU Wei-dong4;ZHAO De-li51.National Office for Cancer Prevention and Control;Cancer Hospital & Institute;Chinese Academy of Medical Sciences;Beijing 100021;China;2.Henan Provincial Office for Cancer Prevention and Control;Henan Cancer Hospital;Zhengzhou 450008;China;3.National Office for Cancer Prevention and Control;Cancer Hospital;Peking Union Medical College;Chinese Academy of Medical Sciences;Beijing 100021;China;4.Department of Epidemiology;Shandong Provincial Linqu Institute of Stomach Cancer Prevention and Control;Weifang 262600;China;5.Department of Medical Affairs;Shandong Provincial Feicheng People’s Hospital;Tai’an 271600;China
ZOU Xiao-nong1;SUN Xi-bin2;CHEN Wan-qing1;ZHENG Rong-shou1;ZHANG Si-wei1;DAI Zhen3;LIU Wei-dong4;ZHAO De-li51.National Office for Cancer Prevention and Control;Cancer Hospital & Institute;Chinese Academy of Medical Sciences;Beijing 100021;China;2.Henan Provincial Office for Cancer Prevention and Control;Henan Cancer Hospital;Zhengzhou 450008;China;3.National Office for Cancer Prevention and Control;Cancer Hospital;Peking Union Medical College;Chinese Academy of Medical Sciences;Beijing 100021;China;4.Department of Epidemiology;Shandong Provincial Linqu Institute of Stomach Cancer Prevention and Control;Weifang 262600;China;5.Department of Medical Affairs;Shandong Provincial Feicheng People’s Hospital;Tai’an 271600;China
..............page:109-114
Effects of SLC22A18 gene on chemosensitivity of U251 human glioma cells
CHU Sheng-hua;ZHU Zhi-an Department of Neurosurgery;Third People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 201900;China
CHU Sheng-hua;ZHU Zhi-an Department of Neurosurgery;Third People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Shanghai 201900;China
..............page:105-108,141
Clinical treatment of acute promyelocytic leukemia during pregnancy:a report of two cases
LI Xiao-qing;HUANG Ren-wei;LIN Dong-jun;XIAO Ruo-zhiDepartment of Hematology;Third Hospital of Sun Yat-Sen University;Guangzhou 510630;China
LI Xiao-qing;HUANG Ren-wei;LIN Dong-jun;XIAO Ruo-zhiDepartment of Hematology;Third Hospital of Sun Yat-Sen University;Guangzhou 510630;China
..............page:145-146
The role of BAG-1 in endoplasmic reticulum stress and the enhancement of cisplatin sensitivity in A549 lung cancer cells induced by tunicamycin
LIU Jing-song1;WANG Ya-di2;LI Yan-xin1;HA Min-wen3;LIU Zhi-liang11.Department of Thoracic Surgery;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China;2.Department of Oncology;Third Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China;3.Department of Oncology;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China
LIU Jing-song1;WANG Ya-di2;LI Yan-xin1;HA Min-wen3;LIU Zhi-liang11.Department of Thoracic Surgery;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China;2.Department of Oncology;Third Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China;3.Department of Oncology;First Affiliated Hospital of Liaoning Medical College;Jinzhou 121001;China
..............page:99-104
Effects of GRIM-19 on chemotherapeutic sensitivity of cisplatin-resistant human lung cancer cell A549/DDP and the expressions of related genes
WU Dao-rong1;2;WANG Tong3;JIANG Zi-feng1;2;LIU Rong-yu1;21.Department of Geriatric Pulmonary;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;2.Respiratory Institute;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;3.Department of Pulmonary;Heifei First People’s Hospital;Hefei 230061;China
WU Dao-rong1;2;WANG Tong3;JIANG Zi-feng1;2;LIU Rong-yu1;21.Department of Geriatric Pulmonary;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;2.Respiratory Institute;First Affiliated Hospital of Anhui Medical University;Hefei 230022;China;3.Department of Pulmonary;Heifei First People’s Hospital;Hefei 230061;China
..............page:92-98
Influences of over-expression of VEGF-C and its inhibition on biological characteristics of NCI-H446 human small-cell lung cancer cells
ZHANG Jie;CHEN Mo;ZHOU Cai-cun;XU Jian-fang;ZHAO Yin-min;SU BoDepartment of Oncology;Shanghai Pulmonary Hospital;Tongji University School of Medicine;Shanghai 200433;China
ZHANG Jie;CHEN Mo;ZHOU Cai-cun;XU Jian-fang;ZHAO Yin-min;SU BoDepartment of Oncology;Shanghai Pulmonary Hospital;Tongji University School of Medicine;Shanghai 200433;China
..............page:79-84